非炎症性前部缺血性视神经病变患者经复方樟柳碱治疗前后血浆内皮素-1浓度的测定
缺血性视神经病变,,缺血性视神经病变；复方樟柳碱；内皮素-1,1资料与方法,2结果,3讨论,【参考文献】
【摘要】 目的 测定非动脉炎性前部缺血性视神经病变(NAION)患者在复方樟柳碱治疗前后血浆中内皮素-1(ET-1)浓度，探讨其变化规律。方法 NAION患者39例，给予复方樟柳碱2ml颞浅动脉旁注射，共治疗21天，所有患者按治疗效果分为3组(A组为治愈，B组为显效或有效，C组为无效)，分别通过放射免疫法(RIA)测定治疗前后血浆ET-1浓度。结果 各组治疗前的血浆ET-1浓度，A、B组高于C组，其差异有显著性(tA，C=4.67，P<0.05；tB，C=4.03，P<0.05)，而A、B组之间差异无显著性(tA，B=1.34，P>0.1)。各组治疗后的血浆ET-1浓度，其分布规律同治疗前(tA，C=4.13，P<0.05；tB，C=3.89，P<0.05；tA，B=0.67，P>0.1)。各组治疗后的血浆ET-1浓度较治疗前均有所下降，A组、B组其治疗前后的浓度差异有显著性(FA=4.78，P<0.05；FB=4.23，P<0.05)，C组治疗前后的浓度差异无显著性(FC=0.78，P>0.1)。结论 复方樟柳碱对NAION患者的治疗效果，可能与血浆ET-1水平有关。【关键词】 缺血性视神经病变；复方樟柳碱；内皮素-1
The concentration of endothelin-1 in patients with NAION before and after treatment by compound anisodine
LENG Yuan-mei.Department of Ophthalmology,The Peoples Hospital of Tongliang,Chongqing 402560,China
【Abstract】 Objective To measure the concentration of plasma endothelin-1(ET-1)in patients with nonarteritic anterior ischemic optic neuropathy (NAION) before and after treatment by compound anisodine and investigate the rule.Methods 39 patients with NAION were treated by compound anisodine which was injected subcutaneously around superficial temporal artery once a day for 21days.All the patients were divided into three groups according to the results after treatment:Groups A: cure; Group B: efficacy; Group C: no efficacy.The plasma levels of ET-1 in 39 cases before and after treatment were measured by radioimmuoassay(RIA).Results The plasma levels of ET-1 before and after treatment in group A and group B were significantly higher than those in group C.There was no significantly difference between group A and group B.The plasma levels of ET-1 in patients after treatment were obviously lower than those before treatment.There was significantly difference in group A and group B but not in group C.Conclusion The efficiency of compound anisodine on patients with NAION may result in the plasma levels of ET-1. ......
您现在查看是摘要页，全文长 7547 字符。